Skip to content
1887

Journal of Medical Microbiology logo Journal of Medical Microbiology

Volume 74, Issue 1

Low cluster of differentiation 4+ T-cell count associated with thrombocytopenia among people living with human immunodeficiency virus-1 receiving antiretroviral in West Papua No Access

Abstract

Anaemia and thrombocytopenia are blood-related irregularities linked to an increased likelihood of disease progression, leading to death in people living with human immunodeficiency virus 1 (PLHIV).

Severe clinical conditions associated with human immunodeficiency 1 (HIV-1) infection may be related to blood irregularities among PLHIV.

The study aimed to examine the factors correlated with blood irregularities among PLHIV receiving antiretroviral treatment in West Papua.

We conducted a study at hospitals in West Papua involving 80 participants who received antiretroviral therapy (ART) and agreed to provide informed consent. Standardized and validated questionnaires were used for data collection. Sequential assessment of haematological and immunological parameters was performed using Sysmex haematology and PIMA CD4+ analyser. Fisher’s exact test and logistic regression analysis were applied, with a significance level set at <0.05, to identify the key factors positively associated with blood irregularities.

The overall incidences of anaemia and thrombocytopenia were 56.3 and 40%, respectively. Fisher’s exact test indicated that anaemia [adjusted odds ratio (AOR): 3.02; 95% confidence interval (CI): 1.160–7.866; <0.05] and low CD4+ T-cell count (AOR: 3.81; 95 % CI: 1.485–9.820, <0.05) were significantly associated with thrombocytopenia. Logistic regression analysis revealed that the most influential factor contributing to thrombocytopenia-related blood irregularities was the clinical CD4+ T-cell count (=3.818; 95% CI: 1.485–9.820, <0.05).

CD4+ T-cell count was indicated as the main factor causing thrombocytopenia among PLHIV receiving ART in West Papua. It is crucial to conduct screening and regular haematological assessments among PLHIV having low CD4+ T-cell counts to mitigate morbidity and mortality risks.

  • Received:
  • Accepted:
  • Published Online:
Keyword(s): anaemia , blood irregularities , CD4+ T-cell , HIV-1 , thrombocytopenia and West Papua
Funding
This study was supported by the:
  • Ministry of Health of the Republic of Indonesia
    • Principal Award Recipient: ApplicableNot
© 2025 The Authors
Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.001958
2025-01-29
2026-01-16

Metrics

Loading full text...

Full text loading...

References

  1. Pramudianti MID, Tahono T. The correlation between thrombocyte and cd4 count in HIV/AIDS patients. Indones J Clin Pathol Med Lab 2011; 17:102–106 [View Article]
     [Google Scholar]
  2. De Santis GC, Brunetta DM, Vilar FC, Brandão RA, de Albernaz Muniz RZ et al. Hematological abnormalities in HIV-infected patients. Int J Infect Dis 2011; 15:e808–11 [View Article] [PubMed]
     [Google Scholar]
  3. Damtie S, Workineh L, Kiros T, Eyayu T, Tiruneh T. Hematological abnormalities of adult HIV-infected patients before and after initiation of highly active antiretroviral treatment at Debre Tabor Comprehensive Specialized Hospital, Northcentral Ethiopia: a cross-sectional study. HIV/AIDS - Res Palliat Care 2021; 13:477–484 [View Article]
     [Google Scholar]
  4. Omoregie R, Omokaro EU, Palmer O, Ogefere HO, Egbeobauwaye A et al. Prevalence of anaemia among HIV-infected patients in Benin City, Nigeria. Tanzan J Health Res 2009; 11:1–4 [View Article] [PubMed]
     [Google Scholar]
  5. Odunukwe N, Idigbe O, Kanki P, Adewole T, Onwujekwe D et al. Haematological and biochemical response to treatment of HIV-1 infection with a combination of nevirapine + stavudine + lamivudine in lagos nigeria. Turkish J Haematol 2005; 22:125–131
     [Google Scholar]
  6. Enawgaw B, Alem M, Addis Z, Melku M. Determination of hematological and immunological parameters among HIV positive patients taking highly active antiretroviral treatment and treatment naïve in the antiretroviral therapy clinic of Gondar University Hospital, Gondar, Northwest Ethiopia: a comparative cross-sectional study. BMC Hematol 2014; 14:1–8 [View Article] [PubMed]
     [Google Scholar]
  7. Melku M, Enawgaw B, Ayana S, Anlay DZ, Kebede A et al. Magnitude of anemia and undernutrition among HIV-infected children who took HAART: a retrospective follow-up study. Am J Blood Res 2020; 10:198–209 [PubMed]
     [Google Scholar]
  8. Durandt C, Potgieter J, Mellet J, Herd C, Khoosal R et al. HIV and haematopoiesis. S Afr Med J 2019; 109:40 [View Article]
     [Google Scholar]
  9. Behler C, Shade S, Gregory K, Abrams D, Volberding P. Anemia and HIV in the antiretroviral era: potential significance of testosterone. AIDS Res Hum Retroviruses 2005; 21:200–206 [View Article] [PubMed]
     [Google Scholar]
  10. Jinna S, Khandhar PB. Thrombocytopenia [Online]. StatPearls Publishing; 2023 https://www.ncbi.nlm.nih.gov/books/NBK542208/ accessed 24 January 2024 [PubMed]
  11. World Health Organization Haemoglobin concentrations for the diagnosis of anaemia and assessment of severity. Vitamin and Mineral Nutrition Information System. [Online]. Geneva. World Health Organization; 2011 https://www.who.int/publications/i/item/WHO-NMH-NHD-MNM-11.1 accessed 24 January 2024
  12. World Health Organization Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: recommendations for a public health approach, 2nd ed. Geneva. World Health Organization Department of HIV/AIDS; 2016 https://www.who.int/publications/i/item/9789241549684 accessed 24 January 2024
  13. Parinitha SS, Kulkarni MH. Haematological changes in HIV infection with correlation to CD4 cell count. Australas Med J 2012; 5:157–162 [View Article]
     [Google Scholar]
  14. Marchionatti A, Parisi MM. Anemia and thrombocytopenia in people living with HIV/AIDS: a narrative literature review. Int Health 2021; 13:98–109 [View Article] [PubMed]
     [Google Scholar]
  15. Gedefaw L, Yemane T, Sahlemariam Z, Yilma D. Anemia and risk factors in HAART naïve and HAART experienced HIV positive persons in South West Ethiopia: a comparative study. PLoS One 2013; 8:e72202 [View Article] [PubMed]
     [Google Scholar]
  16. Takuva S, Maskew M, Brennan AT, Sanne I, Macphail AP et al. Anemia among HIV-infected patients initiating antiretroviral therapy in South Africa: improvement in hemoglobin regardless of degree of immunosuppression and the initiating ART regimen. J Trop Med 2013; 2013:162950 [View Article] [PubMed]
     [Google Scholar]
  17. Taremwa IM, Muyindike WR, Muwanguzi E, Boum Y, Natukunda B. Prevalence of HIV-related thrombocytopenia among clients at Mbarara Regional Referral Hospital, Mbarara, southwestern Uganda. J Blood Med 2015; 6:109–113 [View Article] [PubMed]
     [Google Scholar]
  18. Erhabor O, Ejele OA, Nwauche CA, Buseri FI. Some haematological parameters in human immunodeficiency virus (HIV) infected Africans: the Nigerian perspective. Niger J Med 2005; 14:33–38 [View Article] [PubMed]
     [Google Scholar]
  19. Pretorius E. Platelets in HIV: a guardian of host defence or transient reservoir of the virus?. Front Immunol 2021; 12:649465 [View Article] [PubMed]
     [Google Scholar]
  20. Lodge R, Gilmore JC, Ferreira Barbosa JA, Lombard-Vadnais F, Cohen ÉA. Regulation of CD4 Receptor and HIV-1 Entry by MicroRNAs-221 and -222 during Differentiation of THP-1 Cells. Viruses 2017; 10:1–18 [View Article] [PubMed]
     [Google Scholar]
  21. Yaseen MM, Abuharfeil NM, Yaseen MM, Shabsoug BM. The role of polymorphonuclear neutrophils during HIV-1 infection. Arch Virol 2018; 163:1–21 [View Article] [PubMed]
     [Google Scholar]
  22. Hofer U. HIV hides in platelets. Nat Rev Microbiol 2020; 18:316–317 [View Article] [PubMed]
     [Google Scholar]
  23. Real F, Capron C, Sennepin A, Arrigucci R, Zhu A et al. Platelets from HIV-infected individuals on antiretroviral drug therapy with poor CD4+ T cell recovery can harbor replication-competent HIV despite viral suppression. Sci Transl Med 2020; 12:1–11 [View Article] [PubMed]
     [Google Scholar]
  24. Chabert A, Hamzeh-Cognasse H, Pozzetto B, Cognasse F, Schattner M et al. Human platelets and their capacity of binding viruses: meaning and challenges?. BMC Immunol 2015; 16:26 [View Article] [PubMed]
     [Google Scholar]
  25. Rubenstein DA, Yin W. Platelet-activation mechanisms and vascular remodeling. Compr Physiol 2018; 8:1117–1156 [View Article] [PubMed]
     [Google Scholar]
  26. Chandran A, Kanagasabapathy B, Ramesh C, Nachiappan S, Patil TR et al. HIV-associated thrombocytopenia: profiling hematological changes in the HIV infected and AIDS patients. Ann Clin Lab Res 2020; 8:1–7 [View Article]
     [Google Scholar]
  27. Talargia F, Getacher L. Thrombocytopenia and associated factors among HIV-infected patients in pre- and post-antiretroviral therapy, North East Ethiopia. J Blood Med 2021; 12:741–748 [View Article] [PubMed]
     [Google Scholar]
  28. Akdag D, Knudsen AD, Thudium RF, Kirkegaard-Klitbo DM, Nielsen C et al. Increased risk of anemia, neutropenia, and thrombocytopenia in people with human immunodeficiency virus and well-controlled viral replication. J Infect Dis 2019; 220:1834–1842 [View Article] [PubMed]
     [Google Scholar]
  29. Fekene TE, Juhar LH, Mengesha CH, Worku DK. Prevalence of cytopenias in both HAART and HAART naïve HIV infected adult patients in Ethiopia: a cross sectional study. BMC Hematol 2018; 18:8 [View Article] [PubMed]
     [Google Scholar]
  30. Katemba C, Muzoora C, Muwanguzi E, Mwambi B, Atuhairwe C et al. Hematological abnormalities in HIV-antiretroviral therapy naïve clients as seen at an immune suppression syndrome clinic at Mbarara Regional Referral Hospital, southwestern Uganda. J Blood Med 2018; 9:105–110 [View Article] [PubMed]
     [Google Scholar]
  31. Wondimeneh Y, Muluye D, Ferede G. Prevalence and associated factors of thrombocytopenia among HAART-naive HIV-positive patients at Gondar University Hospital, northwest Ethiopia. BMC Res Notes 2014; 7:1–4 [View Article] [PubMed]
     [Google Scholar]
  32. Shen Y, Wang J, Wang Z, Shen J, Tangkai Qi et al. A cross-sectional study of leukopenia and thrombocytopenia among Chinese adults with newly diagnosed HIV/AIDS. Biosci Trends 2015; 9:91–96 [View Article] [PubMed]
     [Google Scholar]
  33. Fan HW, Guo FP, Li YJ, Li N, Li TS. Prevalence of thrombocytopenia among Chinese adult antiretroviral-naïve HIV-positive patients. Chin Med J (Engl) 2015; 128:459–464 [View Article] [PubMed]
     [Google Scholar]
  34. Nka AD, Sosso SM, Fokam J, Bouba Y, Teto G et al. Thrombocytopenia according to antiretroviral drug combinations, viremia and CD4 lymphocytes among HIV-infected patients in Cameroon: a snapshot from the city of Yaoundé. BMC Res Notes 2019; 12:632 [View Article] [PubMed]
     [Google Scholar]
  35. Awamura T, Nakasone ES, Gangcuangco LM, Subia NT, Bali A-J et al. Platelet and HIV interactions and their contribution to non-AIDS comorbidities. Biomolecules 2023; 13:1608 [View Article] [PubMed]
     [Google Scholar]
  36. Bhardwaj S, Almaeen A, Ahmed Wani F, Thirunavukkarasu A. Hematologic derangements in HIV/AIDS patients and their relationship with the CD4 counts: a cross-sectional study. Int J Clin Exp Pathol 2020; 13:756–763 [PubMed]
     [Google Scholar]
  37. O’Bryan TA, Okulicz JF, Bradley WP, Ganesan A, Wang X et al. Impact of the highly active antiretroviral therapy era on the epidemiology of primary HIV-associated thrombocytopenia. BMC Res Notes 2015; 8:595 [View Article]
     [Google Scholar]
  38. Bisetegn H, Ebrahim H. The prevalence of thrombocytopenia and leucopenia among people living with HIV/AIDS in Ethiopia: a systematic review and meta-analysis. PLoS One 2021; 16:e0257630 [View Article] [PubMed]
     [Google Scholar]
  39. Vannappagari V, Nkhoma ET, Atashili J, Laurent SS, Zhao H. Prevalence, severity, and duration of thrombocytopenia among HIV patients in the era of highly active antiretroviral therapy. Platelets 2011; 22:611–618 [View Article] [PubMed]
     [Google Scholar]
  40. Alkholifi FK, Abdi SAH, Qadri M. Global prevalence and associated clinical markers of thrombocytopenia in people living with HIV: evidence from meta-analysis. Clin Pract 2022; 12:867–875 [View Article] [PubMed]
     [Google Scholar]
  41. Ayanaw MA, Yabeyu AB, Lenjiso G, Kifle ZD. Prevalence and predictors of thrombocytopenia among HAART naive HIV positive patients at Ambo University Referral Hospital. Clin Epidemiol Glob Health 2022; 15:101049 [View Article]
     [Google Scholar]
  42. Rasizadeh R, Ebrahimi F, Zamani Kermanshahi A, Daei Sorkhabi A, Sarkesh A et al. Viruses and thrombocytopenia. Heliyon 2024; 10:e27844 [View Article] [PubMed]
     [Google Scholar]
  43. Davizon-Castillo P, Rowley JW, Rondina MT. Megakaryocyte and platelet transcriptomics for discoveries in human health and disease. Arterioscler Thromb Vasc Biol 2020; 40:1432–1440 [View Article] [PubMed]
     [Google Scholar]
  44. Marcellin F, Spire B, Carrieri MP, Roux P. Assessing adherence to antiretroviral therapy in randomized HIV clinical trials: a review of currently used methods. Expert Rev Anti Infect Ther 2013; 11:239–250 [View Article] [PubMed]
     [Google Scholar]
  45. Hoang NT, Foo TJ, Tran BX, Do NT, Vu GT et al. Structural barriers for retention of HIV/AIDS patients after initiating antiretroviral therapy in outpatient clinics of Vietnam. AIDS Care 2022; 34:992–999 [View Article]
     [Google Scholar]
  46. Naidoo K, Baxter C, Abdool Karim SS. When to start antiretroviral therapy during tuberculosis treatment?. Curr Opin Infect Dis 2013; 26:35–42 [View Article] [PubMed]
     [Google Scholar]
  47. Mi T, Li X, Zhou G, Qiao S, Shen Z et al. HIV disclosure to family members and medication adherence: role of social support and self-efficacy. AIDS Behav 2020; 24:45–54 [View Article] [PubMed]
     [Google Scholar]
  48. Berghoff CR, Gratz KL, Portz KJ, Pinkston M, Naifeh JA et al. The role of emotional avoidance, the patient-provider relationship, and other social support in ART adherence for HIV+ individuals. AIDS Behav 2018; 22:929–938 [View Article] [PubMed]
     [Google Scholar]
  49. Kim J, Lee E, Park BJ, Bang JH, Lee JY. Adherence to antiretroviral therapy and factors affecting low medication adherence among incident HIV-infected individuals during 2009–2016: a nationwide study. Sci Rep 2018; 8:1–8 [View Article]
     [Google Scholar]
  50. Byakika-Tusiime J, Polley EC, Oyugi JH, Bangsberg DR. Free HIV antiretroviral therapy enhances adherence among individuals on stable treatment: implications for potential shortfalls in free antiretroviral therapy. PLoS One 2013; 8:e70375 [View Article] [PubMed]
     [Google Scholar]
  51. Zahra AN, Waluyo A, Yona S, Pakasi TA. Resilience in relation to adherence to antiretroviral therapy in people living with HIV: a qualitative study. Glob Qual Nurs Res 2024; 11:23333936241233449 [View Article] [PubMed]
     [Google Scholar]
  52. Sun L, Qu M, Chen B, Li C, Fan H et al. Effectiveness of mHealth on adherence to antiretroviral therapy in patients living with HIV: meta-analysis of randomized controlled trials. JMIR Mhealth Uhealth 2023; 11:e42799 [View Article] [PubMed]
     [Google Scholar]
/content/journal/jmm/10.1099/jmm.0.001958
Loading
Low cluster of differentiation 4+ T-cell count associated with thrombocytopenia among people living with human immunodeficiency virus-1 receiving antiretroviral in West Papua
J. Med. Microbiol. 74, 001958 (2025); https://doi.org/10.1099/jmm.0.001958
/content/journal/jmm/10.1099/jmm.0.001958
/content/journal/jmm/10.1099/jmm.0.001958
Loading

Data & Media loading...

Most cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An error occurred
Approval was partially successful, following selected items could not be processed due to error